NasdaqCM - Delayed Quote USD

Iterum Therapeutics plc (ITRM)

Compare
1.1700 +0.0800 (+7.34%)
At close: October 18 at 4:00 PM EDT
1.1900 +0.02 (+1.71%)
After hours: October 18 at 5:38 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
38,255.0000
47,468.0000
30,383.0000
24,537.0000
32,126.0000
--
Operating Income
-38,255.0000
-47,468.0000
-30,383.0000
-24,537.0000
-32,126.0000
--
Net Non Operating Interest Income Expense
-1,763.0000
-1,428.0000
-2,361.0000
-5,553.0000
-17,945.0000
--
Other Income Expense
12,063.0000
11,138.0000
-11,389.0000
-60,769.0000
-1,192.0000
--
Pretax Income
-27,955.0000
-37,758.0000
-44,133.0000
-90,859.0000
-51,263.0000
--
Tax Provision
382.0000
613.0000
301.0000
705.0000
743.0000
--
Net Income Common Stockholders
-28,337.0000
-38,371.0000
-44,434.0000
-91,564.0000
-52,006.0000
--
Diluted NI Available to Com Stockholders
-28,337.0000
-38,371.0000
-44,434.0000
-91,564.0000
-52,006.0000
--
Basic EPS
-1.83
-2.73
-3.35
-7.74
-30.01
--
Diluted EPS
-1.83
-2.73
-3.35
-7.74
-30.01
--
Basic Average Shares
15,784.5140
14,059.8610
13,272.6580
11,813.3150
1,736.1790
--
Diluted Average Shares
15,784.5140
14,059.8610
13,272.6580
11,813.3150
1,736.1790
--
Total Operating Income as Reported
-38,255.0000
-47,468.0000
-30,383.0000
-24,537.0000
-32,126.0000
--
Total Expenses
38,255.0000
47,468.0000
30,383.0000
24,537.0000
32,126.0000
--
Net Income from Continuing & Discontinued Operation
-28,337.0000
-38,371.0000
-44,434.0000
-91,564.0000
-52,006.0000
--
Normalized Income
-37,896.7900
-47,105.2400
-48,745.8200
-47,060.2800
-50,980.3500
--
Interest Expense
1,763.0000
1,428.0000
2,361.0000
5,553.0000
15,097.0000
--
Net Interest Income
-1,763.0000
-1,428.0000
-2,361.0000
-5,553.0000
-17,945.0000
--
EBIT
-26,192.0000
-36,330.0000
-41,772.0000
-85,306.0000
-36,166.0000
--
EBITDA
-25,301.0000
-34,580.0000
-39,972.0000
-83,202.0000
-36,005.0000
--
Reconciled Depreciation
891.0000
1,750.0000
1,800.0000
2,104.0000
161.0000
--
Net Income from Continuing Operation Net Minority Interest
-28,337.0000
-38,371.0000
-44,434.0000
-91,564.0000
-52,006.0000
--
Total Unusual Items Excluding Goodwill
12,101.0000
11,056.0000
5,458.0000
-60,964.0000
-1,405.0000
--
Total Unusual Items
12,101.0000
11,056.0000
5,458.0000
-60,964.0000
-1,405.0000
--
Normalized EBITDA
-37,402.0000
-45,636.0000
-45,430.0000
-22,238.0000
-34,600.0000
--
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
--
Tax Effect of Unusual Items
2,541.2100
2,321.7600
1,146.1800
-16,460.2800
-379.3500
--
12/31/2019 - 5/25/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers